WeVote

Bill

Bill

HB 5051

AN ACT RELATING TO RENAMING THE NEW SAKONNET RIVER BRIDGE, AQUIDNECK ISLAND

2025 Regular Session Introduced by Sam Azzinaro and 4 co-sponsors

HB 5051 broadens first responders’ epinephrine options to include nasal sprays and inhalers, with training and civil/criminal immunity protections.

05/06/2025 Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 5051

Summary — HB 5051 (Law enforcement and firefighter access to epinephrine act — MODIFICATIONS)

Status: Referred to second reading (reported without amendment 11/05/2025)
Primary sponsor: Rep. Nancy DeBoer (with multiple co-sponsors)
Bill amends: 2020 PA 312 (MCL 28.821 et seq.), by amending title and sections 1–3 (MCL 28.821, 28.822, 28.823)
Tie-bar: Bill is tie-barred to HB 5049, HB 5050, HB 5052, HB 5053, and HB 5054 — none take effect unless all are enacted

Main purpose

HB 5051 updates the Law Enforcement and Firefighter Access to Epinephrine Act to broaden what devices may be used to deliver epinephrine and to revise related statutory language and immunity rules accordingly. The goal is to allow law enforcement officers and firefighters to possess and administer a wider range of epinephrine delivery products when responding to suspected anaphylaxis.

Key provisions

  • Replaces references to “auto-injectable” epinephrine with the broader term “epinephrine delivery system.”
  • Adds a statutory definition of “epinephrine delivery system” that includes, but is not limited to:
    • epinephrine auto-injectors,
    • epinephrine inhalers,
    • epinephrine nasal sprays.
  • Allows an “eligible entity” (a law enforcement agency or organized fire department) to purchase, store, and distribute epinephrine delivery systems to its trained officers or firefighters.
  • Permits officers or firefighters who have completed required training to administer an epinephrine delivery system to any person they reasonably believe is experiencing anaphylaxis — regardless of whether the person has a prescription or known allergy.
  • Requires completion of training on proper administration before an individual may administer epinephrine under the act.
  • Provides civil immunity:
    • Eligible entities are immune from civil liability for injuries, death, or damages arising from administration unless conduct amounts to gross negligence (as defined in state law).
    • Officers/firefighters are immune from civil liability unless their conduct is willful or wanton misconduct.
  • Provides criminal immunity for purchasing, possessing, distributing, administering, or failing to administer epinephrine delivery systems under the act.
  • Preserves other immunities or defenses available under Michigan law.

Who is affected

  • Law enforcement agencies and organized fire departments (eligible entities) — may acquire and provide epinephrine delivery systems.
  • Law enforcement officers and firefighters — may carry and administer broader types of epinephrine devices after training.
  • Members of the public experiencing suspected anaphylaxis — could receive a wider range of emergency treatments from first responders.

Fiscal and procedural notes

  • House Fiscal Agency: no fiscal impact on the state, local school districts, ISDs, PSAs, LARA, or Department of State Police from HB 5051 and the tied bills.
  • Effective date: The amendatory act does not take effect unless all tied bills (HB 5049, HB 5050, HB 5052, HB 5053, HB 5054) are enacted.
  • Legislative actions: Filed 03/13/2025; reproduced/introduced in the House 09/24/2025; reported to second reading 11/05/2025.

Potential impact (practical)

  • Broadens emergency treatment options available to first responders by authorizing non-injectable epinephrine delivery methods (e.g., nasal spray, inhaler).
  • Maintains training and liability safeguards while extending civil/criminal immunity except for gross negligence or willful/wanton misconduct.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.